Published Studies Related to Novolog Mix 70/30 (Insulin Aspart Protamine Suspension / Insulin Aspart Injection)
Well-designed clinical trials related to Novolog Mix 70/30 (Insulin Aspart Protamine Suspension / Insulin Aspart Injection)
Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. [2004.10]
A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes. [2004.05]
Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. [2004.04]
A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. [2003.11]
Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart. [2000.08]
Other research related to Novolog Mix 70/30 (Insulin Aspart Protamine Suspension / Insulin Aspart Injection)
Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes. [2006.06]
Premixed insulin analogues for the treatment of diabetes mellitus. [2006]
Efficacy of biphasic insulin aspart in patients with type 2 diabetes. [2005]
Biphasic insulin aspart 30: literature review of adverse events associated with treatment. [2005]
Spotlight on insulin aspart in type 1 and 2 diabetes mellitus. [2003]
|
